What are the therapeutic alternatives to dextropropoxyphene in France? A prescribers' survey.

Abstract : About a year after dextropropoxyphene (DXP) withdrawal from the French market, we conducted a survey among members of the French Society of Anesthesia & Intensive Care Medicine (Sfar) and of the French Society of the Study and Treatment of Pain (SFETD) to identify the indications for which this WHO level II analgesic had been prescribed, the prescriber's feedback following withdrawal, and the substitutive analgesics prescribed. DXP had been prescribed by more than 75% of the 430 anaesthesiologists and 230 pain specialists interviewed, mainly for acute and chronic non-cancer pain of moderate intensity. While two thirds of pain specialists were not satisfied with DXP withdrawal, this decision did not affect the majority of anaesthesiologists. In both groups, the main substitutive analgesic was tramadol combined with acetaminophen, while only 24% of prescribers considered acetaminophen alone as a substitute.
Type de document :
Article dans une revue
Anaesthesia Critical Care & Pain Medicine, Elsevier Masson, 2017, 36 (1), pp.15-19. 〈10.1016/j.accpm.2016.01.007〉
Liste complète des métadonnées

Littérature citée [1 références]  Voir  Masquer  Télécharger

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01558315
Contributeur : Laurent Jonchère <>
Soumis le : lundi 11 décembre 2017 - 10:36:48
Dernière modification le : jeudi 28 juin 2018 - 14:38:50
Document(s) archivé(s) le : lundi 12 mars 2018 - 12:18:07

Fichier

What are the therapeutic alter...
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

F Aubrun, E Chrétien, L Letrilliart, M Ginoux, M Belhassen, et al.. What are the therapeutic alternatives to dextropropoxyphene in France? A prescribers' survey.. Anaesthesia Critical Care & Pain Medicine, Elsevier Masson, 2017, 36 (1), pp.15-19. 〈10.1016/j.accpm.2016.01.007〉. 〈hal-01558315〉

Partager

Métriques

Consultations de la notice

159

Téléchargements de fichiers

26